Rank
824
Parexel International
- Previous Rank881
- Revenues ($M)2426
- Revenue Percent Change4.1
- Profits ($M)154.9
- Profits Percent Change4.8
- Assets ($M)2036
- Employees18600
- Market Value — as of March 31, 2017 ($M)3216
Company Info
| CEO | Josef H. von Rickenbach |
| CEO Title | Chairman & Chief Executive Officer |
| Sector | Health Care |
| Industry | Health Care: Pharmacy and Other Services |
| HQ Location | Waltham, MA |
| Website | www.parexel.com |
| Years on Fortune 500 List | - |
| Employees | 18,600 |
Key Financials (Last Fiscal Year)
| Revenues ($M) | $2,426 |
| Profits ($M) | $154.9 |
| Assets ($M) | $2,036 |
| Total Stockholder Equity ($M) | $633 |
| Market Value — as of March 31, 2017 ($M) | $3,216 |
Profit Ratios
| Profit as % of Revenues | 6.4% |
| Profits as % of Assets | 7.6% |
| Profits as % of Stockholder Equity | 24.5% |
Earnings Per Share (Last Fiscal Year)
| Earnings Per Share ($) | 286 |
| EPS % Change (from 2015) | 7.9% |
| EPS % Change (5 year annual rate) | 28.7% |
| EPS % Change (10 year annual rate) | 20.7% |
Total Return
| Total Return to Investors (2016) | -3.5% |
| Total Return to Investors (5 year, annualized) | 25.9% |
| Total Return to Investors (10 year, annualized) | 16.3% |